Barasch Richard A's Form 4 filing
Starling Oncology, Inc. (DFPH) · filed Mar 21, 2023
- Accession no.
- 0001628280-23-008836
- Filed
- Mar 21, 2023
- Trade date
- Mar 17, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 8 non-derivative transactions. Open-market purchases total $27.5K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Barasch Richard ACIK 0001076341 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 17, 2023 | Common stock | PPurchaseAcquired | +10,000 | $0.55 | +$5,500 | 217,193 | Direct | |
| Mar 17, 2023 | Common stock | PPurchaseAcquired | +52 | $0.55 | +$28.6 | 217,245 | Direct | |
| Mar 17, 2023 | Common stock | PPurchaseAcquired | +200 | $0.55 | +$110 | 217,445 | Direct | |
| Mar 17, 2023 | Common stock | PPurchaseAcquired | +9,948 | $0.55 | +$5,471.4 | 227,393 | Direct | |
| Mar 17, 2023 | Common stock | PPurchaseAcquired | +7,654 | $0.55 | +$4,209.7 | 235,047 | Direct | |
| Mar 17, 2023 | Common stock | PPurchaseAcquired | +2,146 | $0.55 | +$1,180.3 | 237,193 | Direct | |
| Mar 17, 2023 | Common stock | PPurchaseAcquired | +10,000 | $0.55 | +$5,500 | 247,193 | Direct | |
| Mar 17, 2023 | Common stock | PPurchaseAcquired | +10,000 | $0.55 | +$5,500 | 257,193 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.